Nutriband (NASDAQ:NTRBW) Shares Down 40.6% – Time to Sell?

Nutriband Inc. (NASDAQ:NTRBW)’s stock price traded down 40.6% on Tuesday . The company traded as low as $0.35 and last traded at $0.2080. Approximately 1,000 shares traded hands during trading, a decline of 51% from the average daily volume of 2,029 shares. The stock had previously closed at $0.35.

Nutriband Stock Down 40.6%

The company has a fifty day moving average of $0.78 and a 200-day moving average of $1.14.

Hedge Funds Weigh In On Nutriband

A hedge fund recently bought a new stake in Nutriband stock. Empery Asset Management LP purchased a new position in Nutriband Inc. (NASDAQ:NTRBW) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 40,218 shares of the company’s stock, valued at approximately $65,000. Nutriband comprises approximately 0.1% of Empery Asset Management LP’s portfolio, making the stock its 20th largest position.

About Nutriband

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.